Clinical bioinformatics desiderata for molecular tumor boards.

导出 OA

翻译打印收藏纠错

作者： Matteo,Pallocca ^[1] ; Martina,Betti ^[2] ; Sara,Baldinelli ^[2] ; Ramona,Palombo ^[1] ; Gabriele,Bucci ^[3] ; Luca,Mazzarella ^[4] ; Giovanni,Tonon ^[5] ; Gennaro,Ciliberto ^[6]

作者单位： Institute of Experimental Endocrinology and Oncology, National Research Council, Via Sergio Pansini, 5, 80131 Naples, Italy. ^[1] Biostatistics, Bioinformatics and Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi, 53, 00144 Rome, Italy. ^[2] Center for OMICS Sciences, IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132 Milan, Italy. ^[3] Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, IRCCS IEO - European Institute of Oncology, Via Adamello 16, 20139 Milan, Italy.;Department of Experimental Oncology, IRCCS IEO - European Institute of Oncology, Via Adamello 16, 20139 Milan, Italy. ^[4] Functional Genomics of Cancer Unit, Division of Experimental Oncology, and Center for Omics Sciences, IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132 Milan, Italy. ^[5] Scientific Direction, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi, 53, 00144 Rome, Italy. ^[6]

关键词 biobanking clinical bioinformatics clinical informatics data engineering decision support tools molecular tumor board molecular tumor registry variant actionability variant annotation

主题词人类(Humans);计算生物学(Computational Biology);肿瘤(Neoplasms);软件(Software);基因组学(Genomics)

DOI 10.1093/bib/bbae447

PMID 39297878

发布时间 2024-10-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交